Answers are grounded in this paper and cite their sources.
AIM OF THE STUDY: To characterize the clinical phenotype of adults with clinically diagnosed and genetically confirmed Dravet syndrome (DS), with particular emphasis on seizure evolution, cognitive and motor impairment, and diagnostic delay. CLINICAL RATIONALE FOR THE STUDY: An increasing number of individuals with DS survive into adulthood and require long-term neurological care. However, the adult phenotype differs from the classical childhood presentation and remains underrecognized in adult neurological practice. Recognition of an age-evolving seizure phenotype, together with intellectual disability, gait and postural abnormalities, and extrapyramidal features, may provide important diagnostic clues and prompt molecular testing in previously undiagnosed adults. MATERIAL AND METHODS: We conducted a multicenter retrospective case series of nine adults (six females and three males) fulfilling clinical diagnostic criteria for DS and carrying a pathogenic or likely pathogenic SCN1A variant. Clinical data were obtained from medical records, neurological examinations, seizure diaries, and psychological assessments performed as part of routine care. Seizure history and evolution, status epilepticus, cognitive and communication impairment, motor phenotype, and treatment history were analyzed. RESULTS: The mean age at evaluation was 27.8 years (range 21-37 years). Seizure onset occurred at a mean age of 6 months, whereas the mean age at molecular diagnosis was 13.2 years, corresponding to a mean diagnostic delay of 12.7 years. Febrile seizures occurred in eight of nine patients and persisted beyond the age of 18 years in three. Generalized tonic-clonic seizures persisted into adulthood in all patients, whereas status epilepticus occurred after the age of 18 years in only one. Intellectual disability was present in all patients and was severe or profound in six; communication impairment was observed in eight. Motor abnormalities were prominent, including gait impairment (9/9), ataxia (8/9), postural abnormalities (8/9), bradykinesia (5/9), hypomimia (5/9), and parkinsonian features (3/9). All patients had been exposed to sodium channel-blocking antiseizure medications before molecular diagnosis, with seizure worsening documented in eight of nine patients. CONCLUSIONS AND CLINICAL IMPLICATIONS: The adult phenotype of DS combines persistent drug-resistant epilepsy with intellectual and communication impairment and prominent motor dysfunction. Although generalized tonic-clonic seizures may persist, other features of the epileptic phenotype, particularly status epilepticus, become less prominent with age. Gait, postural, cerebellar, and extrapyramidal abnormalities may provide important diagnostic clues in adults with infantile-onset epilepsy and intellectual disability. Recognition of this age-evolving phenotype may facilitate molecular diagnosis and support syndrome-specific management in adult neurological practice.
No takes yet. Share an insight, caveat, or question.
Winczewska-Wiktor et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: